Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term safety study of colestilan versus sevelamer in dialysis patients with hyperphosphataemia
2006-003330-15Phase 3Completed
- Sponsor
- Mitsubishi Tanabe Pharma Corporation
- Start
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of colestilan in hyperphosphatemia (2 arms), sponsored by Mitsubishi Tanabe Pharma Corporation. Primary endpoint: Change in safety parameters from baseline. Started Nov 2006; status: completed.
02
Drugs
colestilan
03
Conditions
hyperphosphatemia
Beyond the preview
Go deeper on 2006-003330-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003330-15.